The immunobiology of apotransferrin in type 1 diabetes
Clinical and Experimental Immunology, 05/25/2012
Mangano K et al. – The authors confirmed that patients with newly diagnosed type 1 diabetes manifest significantly lower apoTf serum levels compared to healthy controls and patients with long–lasting disease. The data suggest the apoTf pivotal role in the perpetuation of type 1 diabetes pathology.